The Patent Finder

Kineta Four LLC

Also on record
Records under this name other than patents Kineta Four LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Kineta Four LLC

PatentTitleStatus Expires Confidence
US 9,498,470Antiviral Drugs for Treatment of Arenavirus Infection
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,000,486Antiviral Drugs for Treatment of Arenavirus Infection
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,067,873Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Lapsed on the fee record
Ended Jun 30, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jun 30, 2023From the USPTO record
US 8,754,082Antiviral drugs for treatment of Arenavirus infection
Lapsed on the fee record
Ended Jun 17, 2022 · From the USPTO record
Lapsed on the fee recordEnded Jun 17, 2022From the USPTO record
US 8,461,177Antiviral drugs for treatment of arenavirus infection
Lapsed on the fee record
Ended Jun 11, 2021 · From the USPTO record
Lapsed on the fee recordEnded Jun 11, 2021From the USPTO record
US 8,410,149Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Lapsed on the fee record
Ended Apr 2, 2021 · From the USPTO record
Lapsed on the fee recordEnded Apr 2, 2021From the USPTO record
US 8,148,428Antiviral drugs for treatment of arenavirus infection
Lapsed on the fee record
Ended Apr 3, 2020 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2020From the USPTO record
US 8,106,058Anti-arenaviral compounds
Lapsed on the fee record
Ended Jan 31, 2020 · From the USPTO record
Lapsed on the fee recordEnded Jan 31, 2020From the USPTO record
US 9,199,920Antiviral drugs for treatment of arenavirus infection
Lapsed on the fee record
Ended Dec 1, 2019 · From the USPTO record
Lapsed on the fee recordEnded Dec 1, 2019From the USPTO record
US 9,115,065Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses
Lapsed on the fee record
Ended Aug 25, 2019 · From the USPTO record
Lapsed on the fee recordEnded Aug 25, 2019From the USPTO record
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited